MAR 01, 2016 8:21 AM PST

Viruses May Have An Immune System Just Like Humans

WRITTEN BY: Kara Marker
The first gigantic mimiviruses were discovered in 2007 by a research group in France. They named the virus they found “Mimivirus,” originally thought to be a bacterium because of its size, due to its diameter (0.8 µm) and genome size (1.2Mb) “mimicking” the dimensions of a bacterium (Clinical Infectious Diseases). Almost ten years later, the same group, led by Didier Raoult, PhD, has made another monumental discovery: a CRISPR-like immune system held by mimiviruses.
 
Computer artwork of a particle of the giant mimivirus.


CRISPR system DNA sequences were discovered in bacteria by a Spanish microbiologist named Franciso Mojica in the 1990s. Just like humans, bacteria have to defend themselves against viral infections from microbes that specifically target bacteria, called bacteriophage. The CRISPR system works by keeping a record of short DNA sequences that correspond to sequences of the bacteriophage. When the viruses attack, the CRISPR systems identifies them as a threat and engages certain gene sequences coding for Cas enzymes that break down the bacteriophage DNA. After its discovery, the CRISPR system was “repurposed” as a gene editing technique serving a variety of purposes. 

Now a similar defense system has been discovered in mimiviruses, whose genomes are sometimes larger than some bacterial genomes. They are also visible under a light microscope, and despite similarities to other viruses like smallpox, mimiviruses also have bacteria-like genes that make amino acids, DNA nucleotides, and complex proteins. Mimiviruses also require protection from bacteria and other viruses. Like bacteria, mimiviruses have a specific type of viruses that are “out to get them,” called virophage.

Raoult and his team studied 60 mimivirus strains and their genomes, looking for DNA sequences that correspond to a common virophage, called Zamilon. After finding evidence of such sequences, researchers also found genes encoding enzymes to degrade and unwind DNA, just like Cas enzymes do in the bacterial CRISPR system. Additionally, both systems encode the degrading enzymes adjacent to the DNA sequences that correspond to the the bacteriophage and virophage. 

Raoult believes that this predator-prey relationship between mimiviruses and virophage prompted the evolution of the mimivirus CRISPR-like immune system. In his new study published in Nature, blocking activity from parts of the mimivirus CRISPR-like system greatly increased mimivirus susceptibility to virophage infection. 

“They are facing the same kind of challenge that prokaryotes have when they live in communities,” he said. Raoult also suspects that mimiviruses secrete antibiotic compounds in addition to their CRISPR-like immune system to prevent bacterial infections. This opens a whole new discussion into the possibility of developing new antibiotics from mimiviruses.

Raoult dubbed the CRISPR-like immune system of mimiviruses to be called “MIMIVIRE,” and he believes this distinctive discovery makes a claim for mimiviruses to have their own “branch on the tree of life.”
 

Source: Nature 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 15, 2020
Immunology
Does COVID-19 Attack the Immune System like HIV?
APR 15, 2020
Does COVID-19 Attack the Immune System like HIV?
Researchers from the US and China have found that COVID-19 can destroy T cells, a type of lymphocyte that plays a key ro ...
MAY 26, 2020
Drug Discovery & Development
Everyone Can Produce Antibodies Against COVID-19
MAY 26, 2020
Everyone Can Produce Antibodies Against COVID-19
Researchers at Rockefeller University in New York have found that most people exposed to COVID-19, and who experience sy ...
JUN 10, 2020
Drug Discovery & Development
FDA Approves New Antibiotic for Hospital-Acquired Pneumonia
JUN 10, 2020
FDA Approves New Antibiotic for Hospital-Acquired Pneumonia
The US Food and Drug Administration (FDA) has approved Recarbrio, an antibiotic drug created by pharmaceutical company M ...
JUL 07, 2020
Coronavirus
No Evidence Showing Asthma Increases Severity of COVID-19
JUL 07, 2020
No Evidence Showing Asthma Increases Severity of COVID-19
Scientists have been scrambling to learn as much as possible about the novel coronavirus, which causes the disease COVID ...
AUG 04, 2020
Microbiology
Why the Brain Parasite You May Carry Isn't a Problem
AUG 04, 2020
Why the Brain Parasite You May Carry Isn't a Problem
Toxoplasma gondii is a parasite transmitted by cats and contaminated meat, and it's thought that over 30 million America ...
AUG 05, 2020
Immunology
Intercepting Cancer Cells Before They Can Dodge the Immune System
AUG 05, 2020
Intercepting Cancer Cells Before They Can Dodge the Immune System
The battle that naturally occurs between the body’s immune system and cancerous cells is one that scientists have ...
Loading Comments...